Modern technology remains a privilege, not a right, as families of people with diabetes struggle to afford rising ...
Afrezza is a rapid-acting inhaled human insulin indicated to improve glycemic control in adults with diabetes mellitus.
Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...
Ahead of the earnings release, Wall Street analysts expect its bottom line to grow. Analysts expect Insulet to report a ...
The Insulin Pumps & Continuous Glucose Monitors market offers significant opportunities in strategic planning, supply chain management, and investment decisions. Key trends include evolving ...
'It was a miracle I was diagnosed to begin with.' ...
As Dr Suzanne Wylie, GP and medical adviser for IQdoctor explains, the guidelines state that patients who are well enough to ...
Hi, everyone. My name is Caroline Borowski, and I'm a Vice President here at the JPMorgan Healthcare Investment Bank. It is my pleasure to introduce the CEO of Embecta, Dev Kurdikar. Thank you, ...
Medtronic said Monday it received 510 (k) clearance from the Food and Drug Administration for an app to connect its smart insulin pens with a glucose sensor made by Abbott.
ESTEVE and TerSera Therapeutics LLC announced today that they have entered into an agreement in which ESTEVE will acquire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results